+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transcranial Magnetic Stimulation System Market Size, Share & Trends Analysis Report by Type (Deep Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation, Others), Application, Age Group, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 5649366
The global transcranial magnetic stimulation system market size was estimated at USD 279.46 Million in 2025 and is projected to reach USD 594.49 million by 2033, growing at a CAGR of 9.89% from 2025 to 2033. The global market for transcranial magnetic stimulation system is experiencing significant growth, driven by increasing awareness of neurological disorders, the rising prevalence of neurological and mental health conditions, and a growing number of clinical trials focused on developing innovative TMS systems.

Moreover, the expanding adoption of TMS systems in hospitals and healthcare facilities and a heightened focus on market penetration in both emerging and developed regions are further propelling market expansion. The rising prevalence of neurological disorders, including epilepsy, Parkinson’s disease, Alzheimer’s disease, obsessive-compulsive disorder (OCD), and depression, is a significant driver for the TMS system industry. According to the WHO data published in February 2024, around 50 million people globally are living with epilepsy. In addition, data from the Alzheimer’s Association report published in April 2024 estimates that 6.90 million Americans aged 65 and older are affected by Alzheimer’s dementia.

In addition, the WHO reported in August 2025 that approximately 5.7% of the global adult population suffers from depressive disorders. In addition, the study published by the National Library of Medicine in February 2024 reports that OCD is a prevalent disorder that affects around 1% to 3% of the global population. This considerable burden of neurological conditions is expected to fuel the demand for TMS systems, which use magnetic fields to modulate brain activity non-invasively. TMS has proven effective in treating depression and shows promise in managing other neurological disorders.

Furthermore, the growing burden of neurological disorders remains considerable across both developing and developed nations, driving the demand for advanced treatment technologies. For instance, according to the National Institute of Mental Health, an estimated 21.0 million adults in the U.S. experienced at least one major depressive episode in 2021, accounting for 8.3% of the adults. This prevalence highlights the growing need for effective, non-invasive treatment options such as transcranial magnetic stimulation systems.

Companies are endlessly upgrading their existing products by incorporating advanced features and improving user experience to meet the growing needs of researchers and medical professionals. For instance, in July 2025, the updated Magstim Rapid Transcranial Magnetic Stimulation Research System received FDA approval. This enhanced system offers a sleek 15” touchscreen and user-friendly software, thus providing an intuitive interface. Its Windows-based platform allows greater compatibility and all-in-one integration with external devices.

Global Transcranial Magnetic Stimulation System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global transcranial magnetic stimulation system market report based on type, application, age group, and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Deep Transcranial Magnetic Stimulation
  • Repetitive Transcranial Magnetic Stimulation
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Alzheimer’s Disease
  • Depression
  • Parkinson’s Disease
  • Epilepsy
  • Others

Age Group Outlook (Revenue, USD Million, 2021-2033)

  • Adults
  • Children

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. Age Group
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia-Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Transcranial Magnetic Stimulation System Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Neurological Disorders
3.2.1.2. Technological Advancements
3.2.1.3. Rising Awareness About Neurological Disorders and Treatment Options
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of Alternative Treatments
3.2.3. Market Opportunities Analysis
3.2.3.1. Increasing Clinical Trials
3.2.3.2. Regulatory Approvals Expanding Age Demographics
3.2.3.3. Expanding Applications
3.2.3.4. Strategic Partnerships & Acquisitions
3.2.3.5. Expansion Into Emerging Economies
3.2.4. Market Challenges Analysis
3.2.4.1. Shortage of Neurologists and Mental Health Professionals
3.3. Transcranial Magnetic Stimulation System Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Transcranial Magnetic Stimulation System Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Transcranial Magnetic Stimulation System Market: Type Movement Analysis & Market Share, 2024 & 2030
4.3. Deep Transcranial Magnetic Stimulation
4.3.1. Deep Transcranial Magnetic Stimulation Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Repetitive Transcranial Magnetic Stimulation
4.4.1. Repetitive Transcranial Magnetic Stimulation Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Others
4.5.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Transcranial Magnetic Stimulation System Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Transcranial Magnetic Stimulation System Market: Application Movement Analysis & Market Share, 2024 & 2030
5.3. Alzheimer’s Disease
5.3.1. Alzheimer’s Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Depression
5.4.1. Depression Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Parkinson’s Disease
5.5.1. Parkinson’s Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Epilepsy
5.6.1. Epilepsy Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Transcranial Magnetic Stimulation System Market: Age Group Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Transcranial Magnetic Stimulation System Market: Age Group Movement Analysis & Market Share, 2024 & 2030
6.3. Adults
6.3.1. Adults Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Children
6.4.1. Children Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Transcranial Magnetic Stimulation System Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Transcranial Magnetic Stimulation System Market: Regional Movement Analysis & Market Share, 2024 & 2030
7.3. North America
7.3.1. North America Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Scenario
7.3.2.4. Reimbursement Scenario
7.3.2.5. U.S. Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Scenario
7.3.3.4. Reimbursement Scenario
7.3.3.5. Canada Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Scenario
7.3.4.4. Reimbursement Scenario
7.3.4.5. Mexico Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4. Europe
7.4.1. Europe Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. Reimbursement Scenario
7.4.2.5. UK Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. Reimbursement Scenario
7.4.3.5. Germany Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Scenario
7.4.4.4. Reimbursement Scenario
7.4.4.5. France Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Scenario
7.4.5.4. Reimbursement Scenario
7.4.5.5. Italy Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Scenario
7.4.6.4. Reimbursement Scenario
7.4.6.5. Spain Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Scenario
7.4.7.4. Reimbursement Scenario
7.4.7.5. Denmark Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Scenario
7.4.8.4. Reimbursement Scenario
7.4.8.5. Sweden Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Scenario
7.4.9.4. Reimbursement Scenario
7.4.9.5. Norway Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Asia-Pacific
7.5.1. Asia-Pacific Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. Reimbursement Scenario
7.5.2.5. Japan Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Reimbursement Scenario
7.5.3.5. China Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. Reimbursement Scenario
7.5.4.5. India Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Scenario
7.5.5.4. Reimbursement Scenario
7.5.5.5. South Korea Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Scenario
7.5.6.4. Reimbursement Scenario
7.5.6.5. Australia Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Scenario
7.5.7.4. Reimbursement Scenario
7.5.7.5. Thailand Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Latin America
7.6.1. Latin America Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. Reimbursement Scenario
7.6.2.5. Brazil Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. Reimbursement Scenario
7.6.3.5. Argentina Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Middle East & Africa
7.7.1. Middle East & Africa Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Scenario
7.7.2.4. Reimbursement Scenario
7.7.2.5. South Africa Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Scenario
7.7.3.4. Reimbursement Scenario
7.7.3.5. Saudi Arabia Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Scenario
7.7.4.4. Reimbursement Scenario
7.7.4.5. UAE Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Scenario
7.7.5.4. Reimbursement Scenario
7.7.5.5. Kuwait Transcranial Magnetic Stimulation System Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Nexstim
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. BrainsWay
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Magstim (Welcony)
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. MagVenture A/S
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. ENeura, Inc.
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Product Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. NeuroStar (Neuronetics)
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Product Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Neurosoft
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Product Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. CloudNeuro
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Product Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. Soterix Medical Inc.
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Product Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Brain Ultimate Inc.
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Product Benchmarking
8.2.10.4. Strategic Initiatives
8.2.11. DEYMED Diagnostic s.r.o.
8.2.11.1. Company Overview
8.2.11.2. Financial Performance
8.2.11.3. Product Benchmarking
8.2.11.4. Strategic Initiatives
8.2.12. Salience TMS (Salience Health)
8.2.12.1. Company Overview
8.2.12.2. Financial Performance
8.2.12.3. Product Benchmarking
8.2.12.4. Strategic Initiatives
8.2.13. NeuroQore (Ontario Brain Institute)
8.2.13.1. Company Overview
8.2.13.2. Financial Performance
8.2.13.3. Product Benchmarking
8.2.13.4. Strategic Initiatives
8.2.14. SEBERS Medical
8.2.14.1. Company Overview
8.2.14.2. Financial Performance
8.2.14.3. Product Benchmarking
8.2.14.4. Strategic Initiatives
8.2.15. Neurocare group AG (MAG & More)
8.2.15.1. Company Overview
8.2.15.2. Financial Performance
8.2.15.3. Product Benchmarking
8.2.15.4. Strategic Initiatives
8.2.16. Shenzhen Yingchi Technology Co., Ltd.
8.2.16.1. Company Overview
8.2.16.2. Financial Performance
8.2.16.3. Product Benchmarking
8.2.16.4. Strategic Initiatives
8.2.17. Shanghai Goodmed Medical Device Co., Limited
8.2.17.1. Company Overview
8.2.17.2. Financial Performance
8.2.17.3. Product Benchmarking
8.2.17.4. Strategic Initiatives
8.2.18. Guangzhou MeCan Medical Limited
8.2.18.1. Company Overview
8.2.18.2. Financial Performance
8.2.18.3. Product Benchmarking
8.2.18.4. Strategic Initiatives
8.2.19. Others
8.2.19.1. Company Overview
8.2.19.2. Financial Performance
8.2.19.3. Product Benchmarking
8.2.19.4. Strategic Initiatives
8.3. Heat Map Analysis/ Company Market Position Analysis
8.4. Company Market Share Analysis, 2024
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Transcranial magnetic stimulation system market, by country, 2021-2033 (USD Million)
Table 4 North America Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 5 North America Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 6 North America Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 7 North America Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 8 North America Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 9 U.S. Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 10 U.S. Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 11 U.S. Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 12 Canada Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 13 Canada Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 14 Canada Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 15 Mexico Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 16 Mexico Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 17 Mexico Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 18 Europe Transcranial magnetic stimulation system market, by country, 2021-2033 (USD Million)
Table 19 Europe Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 20 Europe Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 21 Europe Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 22 UK Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 23 UK Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 24 UK Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 25 Germany Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 26 Germany Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 27 Germany Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 28 France Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 29 France Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 30 France Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 31 Italy Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 32 Italy Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 33 Italy Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 34 Spain Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 35 Spain Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 36 Spain Transcranial magnetic stimulation system market, by age group, 2021-2033 (USD Million)
Table 37 Norway Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 38 Norway Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 39 Sweden Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 40 Sweden Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 41 Denmark Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 42 Denmark Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 43 Asia-Pacific Transcranial magnetic stimulation system market, by country, 2021-2033 (USD Million)
Table 44 Asia-Pacific Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 45 Asia-Pacific Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 46 China Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 47 China Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 48 Japan Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 49 Japan Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 50 India Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 51 India Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 52 Australia Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 53 Australia Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 54 South Korea Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 55 South Korea Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 56 Thailand Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 57 South Korea Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 58 Latin America Transcranial magnetic stimulation system market, by country, 2021-2033 (USD Million)
Table 59 Latin America Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 60 Latin America Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 61 Brazil Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 62 Brazil Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 63 Argentina Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 64 Argentina Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 65 Middle East & Africa Transcranial magnetic stimulation system market, by country, 2021-2033 (USD Million)
Table 66 Middle East & Africa Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 67 Middle East & Africa Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 68 South Africa Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 69 South Africa Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 70 Saudi Arabia Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 71 Saudi Arabia Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 72 UAE Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 73 UAE Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
Table 74 Kuwait Transcranial magnetic stimulation system market, by type, 2021-2033 (USD Million)
Table 75 Kuwait Transcranial magnetic stimulation system market, by application, 2021-2033 (USD Million)
List of Figures
Figure 1 Information procurement
Figure 2 Transcranial magnetic stimulation system market segmentation
Figure 3 Market research process
Figure 4 Information procurement process
Figure 5 Primary research pattern
Figure 6 Transcranial magnetic stimulation system market snapshot, 2024 (USD Million)
Figure 7 Segment snapshot, USD Million
Figure 8 Competitive landscape snapshot
Figure 9 Penetration & growth prospect mapping, by Type
Figure 10 Market driver analysis (Current & future impact)
Figure 11 Market restraint analysis (Current & future impact)
Figure 12 Market opportunity analysis (Current & future impact)
Figure 13 Primary market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Deep transcranial magnetic stimulation market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Repetitive transcranial magnetic stimulation market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Alzheimer’s Disease market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 18 Depression market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 19 Parkinson’s Disease market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Epilepsy market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Adults market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Children market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Transcranial magnetic stimulation system market: Regional key takeaways (USD Million)
Figure 25 Transcranial magnetic stimulation system market: Regional outlook, 2023 & 2030 (USD Million)
Figure 26 North America Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 U.S. Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Canada Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Mexico Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Europe Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 UK Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Germany Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 France Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Spain Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Italy Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Sweden Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Norway Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Denmark Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Asia-Pacific Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 China Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Japan Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 India Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 South Korea Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Australia Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Thailand Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Latin America Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Brazil Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Argentina Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Middle East and Africa Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 South Africa Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Saudi Arabia Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 UAE Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Kuwait Transcranial magnetic stimulation system market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 List of key emerging companies
Figure 55 Company market share analysis, 2024
Figure 56 Market differentiators
Figure 57 Competitive dashboard analysis
Figure 58 Regional network map

Companies Mentioned

The leading players profiled in this Transcranial Magnetic Stimulation System market report include:
  • Nexstim
  • BrainsWay
  • Magstim (Welcony)
  • MagVenture A/S
  • eNeura, Inc.
  • NeuroStar (Neuronetics)
  • Neurosoft
  • CloudNeuro
  • Soterix Medical Inc.
  • Brain Ultimate Inc.
  • DEYMED Diagnostic s.r.o.
  • Salience TMS (Salience Health)
  • NeuroQore (Ontario Brain Institute)
  • SEBERS Medical
  • neurocare group AG (MAG & More)
  • Shenzhen Yingchi Technology Co., Ltd.
  • Shanghai Goodmed Medical Device Co., Limited
  • Guangzhou MeCan Medical Limited
  • Others

Table Information